CD44 is one of two well-characterized receptors for hyaluronic acid (HA) [102], and we have recently reported effective sensitization of human KSHV-infected lymphoma cells to chemotherapy using various approaches for interfering with HA-receptor interactions [103]. The gene discussed is CD44; the disease is lymphoma.